Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl

被引:33
作者
Birnbaum, DT
Brannon-Peppas, L
机构
[1] Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA
[2] Biogel Technol Inc, Indianapolis, IN 46268 USA
关键词
nanoparticles; degradation; molecular weight distribution; PLGA; drug delivery;
D O I
10.1163/15685620360511155
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The molecular dynamics of the degradation process of poly(lactic-co-glycolic acid) nanospheres were investigated during the degradation process usually observed when these polymers are used as controlled release carriers. The molecular weight distribution of PLGA samples was determined over a period of 32 days by accurately analyzing the molecular weight distribution of the polymer as a function of time as degradation progressed. The molecular weight distribution shifted gradually to lower average molecular weights over 32 days, with significantly smaller molecular weight components appearing at 8-12 days. In addition, the degradation of nanospheres containing epirubicin HCl was analyzed and increasing the amount of epirubicin from 1.7 to 3.4 to 6.7 wt% was found to hasten the degradation of the nanoparticles and subsequently affect the release behavior from these particles. This is believed to be the first time that such molecular dynamics have been presented for the degradation of PLGA nanoparticle formulations containing a drug for controlled delivery.
引用
收藏
页码:87 / 102
页数:16
相关论文
共 19 条
[1]  
[Anonymous], 1980, EXPT METHODS POLYM C
[2]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[3]   Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles [J].
Birnbaum, Duane T. ;
Kosmala, Jacqueline D. ;
Brannon-Peppas, Lisa .
JOURNAL OF NANOPARTICLE RESEARCH, 2000, 2 (02) :173-181
[4]   RECENT ADVANCES ON THE USE OF BIODEGRADABLE MICROPARTICLES AND NANOPARTICLES IN CONTROLLED DRUG-DELIVERY [J].
BRANNONPEPPAS, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) :1-9
[5]  
COUVREUR P, 1995, EUR J PHARM BIOPHARM, V41, P2
[6]   Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles [J].
Dunne, M ;
Corrigan, OI ;
Ramtoola, Z .
BIOMATERIALS, 2000, 21 (16) :1659-1668
[7]   INFLUENCE OF POLY(DL-LACTIDE) NANOCAPSULES ON THE BILIARY CLEARANCE AND ENTEROHEPATIC CIRCULATION OF INDOMETHACIN IN THE RABBIT [J].
FAWAZ, F ;
BONINI, F ;
GUYOT, M ;
LAGUENY, AM ;
FESSI, H ;
DEVISSAGUET, JP .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :750-756
[8]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[9]  
Gonzalez MF, 1999, J APPL POLYM SCI, V71, P1223, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1223::AID-APP2>3.0.CO
[10]  
2-I